Credits: 0.25 AMA PRA Category 1 Credits™, 0.25 ABIM MOC or 0.35 AANP, including 0.17 AANP Pharm

Overview: Explore the evolving landscape of COVID-19 treatment in this brief podcast. Topics reviewed include updates to payments for antivirals, areas of clinician confusion around antiviral therapy use and managing drug interactions, the status of COVID-19 rebound, and long COVID. Stay informed to provide optimal patient care following the end of the COVID-19 public health emergency.